Opus Genetics, Inc. Common Stock (NASDAQ: IRD) last traded at $4.05, down 1.70% on the session. The quote above updates while this page is open; the figures below are drawn from Opus Genetics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Opus Genetics, Inc. Common Stock trades on NASDAQ under the ticker IRD. Its market capitalisation is $336.94 million.
Valuation measures for Opus Genetics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $336.94M |
|---|---|
| Enterprise value | $354.09M |
| Price / sales | 34.19 |
| Beta | 1.19 |
Trailing-twelve-month figures tagged in Opus Genetics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $9.86M |
|---|---|
| Net income (TTM) | -$107.61M |
| EPS (TTM) | -$1.33 |
| Operating margin | -513.47% |
| Cash | $88.81M |
Range and volume for IRD over the past 52 weeks.
| 52-week high | $5.81 |
|---|---|
| 52-week low | $1.12 |
| Volume | 1.04M |
| Average volume | 956.4K |
| Previous close | $4.12 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.